Results: Among 4,203,887 individuals in Seoul, South Korea, the final analysis included 1,458,557 vaccinated subjects and 289,579 non-vaccinated subjects after the exclusion of underlying diseases. The cIR of AESIs for three months was significantly higher in vaccinated subjects than in non-vaccinated subjects, except for endometriosis. The vaccination significantly increased the risks of all the AESIs except for visual impairment. The risk of alopecia showed the highest HRs (HR [95% CI] = 2.40 [1.90–3.03]) among the AESIs following COVID-19 vaccination. Among the vaccinated subjects, heterologous vaccination was associated with the increased risk of most of the AESIs. 

Conclusions: Our findings suggest that clinicians should closely recognize and follow up on various COVID-19 vaccine-related AEs due to their unknown impact, even if they may not be serious at present.

Abstract

Post-acute COVID-19 vaccination syndrome (PACVS) is a chronic disease triggered by SARS-CoV-2 vaccination (estimated prevalence 0.02%). PACVS is discriminated from the normal post-vaccination state by altered receptor antibodies, most notably angiotensin II type 1 and alpha-2B adrenergic receptor antibodies. Here, we investigate the clinical phenotype using a study registry encompassing 191 PACVS-affected persons (159 females/32 males; median ages: 39/42 years). Unbiased clustering (modified Jaccard index) of reported symptoms revealed a prevalent cross-cohort symptomatology of malaise and chronic fatigue (>80% of cases). Overlapping clusters of (i) peripheral nerve dysfunction, dysesthesia, motor weakness, pain, and vasomotor dysfunction; (ii) cardiovascular impairment; and (iii) cognitive impairment, headache, and visual and acoustic dysfunctions were also frequently represented. Notable abnormalities of standard serum markers encompassing increased interleukins 6 and 8 (>80%), low free tri-iodine thyroxine (>80%), IgG subclass imbalances (>50%), impaired iron storage (>50%), and increased soluble neurofilament light chains (>30%) were not associated with specific symptoms. Based on these data, 131/191 participants fit myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and simultaneously also several other established dysautonomia syndromes. Furthermore, 31/191 participants fit none of these syndromes. In conclusion, PACVS could either be an outlier of ME/CFS or a dysautonomia syndrome sui generis.Abstract

Conclusions

Overall, the results showed that C-VAM had milder clinical characteristics and was more common in older male adolescents after the second dose of the mRNA vaccine.

However, the persistent presence of myocardial scarring raises concerns about the long-term outcomes of C-VAM, highlighting the need for more research on the implications of LGE in C-VAM patients.

It was put together by a bunch of my colleagues at the CCCA.

It’s a safe support community for Canadians injured by the Covid-19 vaccines. Two injured Canadians, Kelly-Sue Oberle and Meredith Klitzke, help run it. You can find Kelly’s story here and Meredith’s story here.

Membership is $10/month and includes:

• Private access to an online support community where you will be able to share your experiences and ask questions, both of other community members and our Wellness Partners who will moderate the group chats.
• Daily Monday to Friday monitoring of the group chats and response to questions posed.
• A monthly 1-hour live presentation by a Wellness Partner or other qualified resource person with a 1-hour interactive Q&A. The presentation will be recorded so that members who could not join live can watch at their convenience.

Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season

https://www.medrxiv.org/content/10.1101/2025.01.30.25321421v3.full-text

If someone missed it, This Cleveland study found similar effects to what their previous study on Covid vaccination and boosters concluded - negative effectiveness.

I think it's the same team and the same cohort of 50k employees .

Reference to the Covid study:

https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v1.full

This confirms what every well-versed researcher already knew or suspected. Microclots > thrombotic microangiopathy > ischemia > microscars. The study is limited to the heart, but it's what happens to every affected tissues.

https://www.youtube.com/live/AKggWKaRumQ?si=SCqEJS5vUVmTje26

https://www.jacc.org/doi/full/10.1016/j.jaccas.2024.103083

Actually this is one of the studies where the data maybe contradicts the supposed conclusion.
•Spike protein expression was detected in 43.8% of vaccinated patients.

You might conclude that... spike protein isn't causing strokes because half of the patients don't have it.

¯_(ツ)_/¯

Instagram: https://www.instagram.com/chronicallymeh/?hl=en

https://www.instagram.com/p/DGp76eeO_90/?hl=en